Director - Audit & Assurance
Jessica has over a decade of accounting experience, specialising in providing audit and assurance services. Jessica currently manages a portfolio of companies publicly listed on the ASX and NASDAQ, and private entities in a broad range of industries.
Having worked out in industry in the United Kingdom for 2 years, Jessica can appreciate the audit process from her clients’ perspective and is passionate about her clients and providing exceptional client service.
Jessica has strong commercial experience in the Life Science and Manufacturing space through knowledge gained from working with a range of businesses in these sectors, her involvement in their industry teams at Grant Thornton and her participation in industry events and associations. She supports the strategic ambitions of Life Science and Manufacturing organisations across all stages of the development life cycle.
Jessica has valuable experience in ensuring businesses manage internal controls effectively, including with Public Company Accounting Oversight Board (PCAOB) audits.
Experience
- Statutory financial statement audits of privately-owned and publicly listed entities (including ASX-listed entities and entities listed on the NASDAQ)
- Internal Control over Financial Reporting (ICFR) audits
- Public Company Accounting Oversight Board (PCAOB) audits
- Bachelor of Business (Accounting), Monash University
- Member of Chartered Accountants Australia and New Zealand (CAANZ)
Latest Articles
View more
Manufacturing Benchmarks 2024: Paving the way for sustainable growth
ReportThe manufacturing sector has demonstrated remarkable resilience and adaptability, achieving steady growth through effective cost management and strategic investments despite economic challenges.
The state of Australian Manufacturing: 2023 Manufacturing benchmarks
ReportThis analysis of Australian mid-sized manufacturers has shown a positive outlook, with average year-on-year sales growing by 6.7 per cent in 2023. This growth can predominantly be attributed to increased capital expenditure and investing into emerging technologies. The outlook is particularly promising for business with revenue over $100m, whose scale has supported ongoing success through stronger forecasting linked to better pricing agreements and growing market shares due to their steady inventory.
